(Q30353490)

3 November 2017

Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice. (English)

1 reference

3 November 2017

1 reference

Jiahai Lu

1

1 reference

3 November 2017

Zhongmin Guo

2

1 reference

3 November 2017

Xinghua Pan

3

1 reference

3 November 2017

Guoling Wang

4

1 reference

3 November 2017

Dingmei Zhang

5

1 reference

3 November 2017

Yanbin Li

6

1 reference

3 November 2017

Bingyan Tan

7

1 reference

3 November 2017

Liping Ouyang

8

1 reference

3 November 2017

Xinbing Yu

9

1 reference

3 November 2017

23 March 2006

1 reference

3 November 2017

1 reference

3 November 2017

7

1 reference

3 November 2017

43

1 reference

https://scigraph.springernature.com/pub.10.1186/1465-9921-7-43

3 November 2017

0 references

cites work

Equine rabies immunoglobulin: a study on its clinical safety.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459145

Probable person-to-person transmission of avian influenza A (H5N1)

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459145

Avian influenza H5N1 in tigers and leopards

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459145

Avian influenza--a challenge to global health care structures

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459145

From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459145

Confronting the avian influenza threat: vaccine development for a potential pandemic.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459145

Intravenous immunoglobulin for infectious diseases: back to the pre-antibiotic and passive prophylaxis era?

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459145

Adoptive transfer of immunity: a new strategy to interfere with severe hepatitis virus reinfection after woodchuck liver transplantation

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459145

Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459145

Virus-neutralizing activity mediated by the Fab fragment of a hemagglutinin-specific antibody is sufficient for the resolution of influenza virus infection in SCID mice

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459145

Do not underestimate the power of antibodies--lessons from adoptive transfer of antibodies against HIV.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459145

Passive immunity in prevention and treatment of infectious diseases

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459145

Antibodies for the prevention and treatment of viral diseases

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459145

A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459145

Characterization of avian H5N1 influenza viruses from poultry in Hong Kong

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459145

Human influenza virus A/HongKong/156/97 (H5N1) infection

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459145

Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459145

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459145

Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459145

Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998.

3 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-43

Avian H5N1 influenza in cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-43

Public health. Public health risk from the avian H5N1 influenza epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-43

Effective prophylaxis of influenza A virus pneumonia in mice by topical passive immunotherapy with polyvalent human immunoglobulins or F(ab')2 fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-43

Successful clearance of hepatitis B virus after allogeneic stem cell transplantation: beneficial combination of adoptive immunity transfer and lamivudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-43

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-43

A protocol for ‘enhanced pepsin digestion’: a step by step method for obtaining pure antibody fragments in high yield from serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-43

Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, Vero-cell rabies vaccine

21 January 2018

1 reference

12 December 2020

Vasoactive side effects of intravenous immunoglobulin preparations in a rat model and their treatment with recombinant platelet-activating factor acetylhydrolase

1 reference

12 December 2020

Purification of specific heterologous F(ab)2 fragments with DEAE-Zeta-Prep cartridges for ion-exchange chromatography

1 reference

12 December 2020

Key role of macrophages in hypotensive side effects of immunoglobulin preparations. Studies in an animal model

1 reference

12 December 2020

Passive transfer of scrub typhus plasma to patients with AIDS: a descriptive clinical study

1 reference

12 December 2020

Identifiers

DOI

10.1186/1465-9921-7-43

1 reference

Dimensions Publication ID

3 November 2017

0 references

1 reference

3 November 2017

1 reference